Immunogen (IMGN) Announces Initiation of PCA062 Phase 1; Triggers $5M Milestone (NVS)
Tweet Send to a Friend
Immunogen (NASDAQ: IMGN) disclosed the following Thursday:On May 20, 2015, Novartis Institutes for BioMedical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
